246 related articles for article (PubMed ID: 36812119)
1. Analysis of 3.5 million SARS-CoV-2 sequences reveals unique mutational trends with consistent nucleotide and codon frequencies.
Fumagalli SE; Padhiar NH; Meyer D; Katneni U; Bar H; DiCuccio M; Komar AA; Kimchi-Sarfaty C
Virol J; 2023 Feb; 20(1):31. PubMed ID: 36812119
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of human coronaviruses focusing on nucleotide variability and synonymous codon usage patterns.
Das JK; Roy S
Genomics; 2021 Jul; 113(4):2177-2188. PubMed ID: 34019999
[TBL] [Abstract][Full Text] [Related]
3. Codon usage divergence in Delta variants (B.1.617.2) of SARS-CoV-2.
Li G; Zhang L; Xue P
Infect Genet Evol; 2022 Jan; 97():105175. PubMed ID: 34871776
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 continuously optimizes its codon usage to adapt to human lung environment.
Wang Y; Li Z; Wang X; Jiang W; Jiang W
J Appl Genet; 2023 Dec; 64(4):831-837. PubMed ID: 37740828
[TBL] [Abstract][Full Text] [Related]
5. Codon usage analysis of zoonotic coronaviruses reveals lower adaptation to humans by SARS-CoV-2.
Huang W; Guo Y; Li N; Feng Y; Xiao L
Infect Genet Evol; 2021 Apr; 89():104736. PubMed ID: 33516969
[TBL] [Abstract][Full Text] [Related]
6. Relative synonymous codon usage of ORF1ab in SARS-CoV-2 and SARS-CoV.
Li G; Zhang L; Du N
Genes Genomics; 2021 Nov; 43(11):1351-1359. PubMed ID: 34228320
[TBL] [Abstract][Full Text] [Related]
7. A comparative genomics-based study of positive strand RNA viruses emphasizing on SARS-CoV-2 utilizing dinucleotide signature, codon usage and codon context analyses.
Saha J; Bhattacharjee S; Pal Sarkar M; Saha BK; Basak HK; Adhikary S; Roy V; Mandal P; Chatterjee A; Pal A
Gene Rep; 2021 Jun; 23():101055. PubMed ID: 33615042
[TBL] [Abstract][Full Text] [Related]
8. Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic.
Mogro EG; Bottero D; Lozano MJ
Virology; 2022 Mar; 568():56-71. PubMed ID: 35134624
[TBL] [Abstract][Full Text] [Related]
9. Evidence for Strong Mutation Bias toward, and Selection against, U Content in SARS-CoV-2: Implications for Vaccine Design.
Rice AM; Castillo Morales A; Ho AT; Mordstein C; Mühlhausen S; Watson S; Cano L; Young B; Kudla G; Hurst LD
Mol Biol Evol; 2021 Jan; 38(1):67-83. PubMed ID: 32687176
[TBL] [Abstract][Full Text] [Related]
10. Analysis of codon usage of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and its adaptability in dog.
Dutta R; Buragohain L; Borah P
Virus Res; 2020 Oct; 288():198113. PubMed ID: 32771430
[TBL] [Abstract][Full Text] [Related]
11. Global SNP analysis of 11,183 SARS-CoV-2 strains reveals high genetic diversity.
Yuan F; Wang L; Fang Y; Wang L
Transbound Emerg Dis; 2021 Nov; 68(6):3288-3304. PubMed ID: 33207070
[TBL] [Abstract][Full Text] [Related]
12. Optimization and Deoptimization of Codons in SARS-CoV-2 and Related Implications for Vaccine Development.
Wu X; Shan KJ; Zan F; Tang X; Qian Z; Lu J
Adv Sci (Weinh); 2023 Aug; 10(23):e2205445. PubMed ID: 37267926
[TBL] [Abstract][Full Text] [Related]
13. The Evolution of Severe Acute Respiratory Syndrome Coronavirus-2 during Pandemic and Adaptation to the Host.
Hussain S; Rasool ST; Pottathil S
J Mol Evol; 2021 Jul; 89(6):341-356. PubMed ID: 33993372
[TBL] [Abstract][Full Text] [Related]
14. Genome-Wide Analysis of Codon Usage Patterns of SARS-CoV-2 Virus Reveals Global Heterogeneity of COVID-19.
Khattak S; Rauf MA; Zaman Q; Ali Y; Fatima S; Muhammad P; Li T; Khan HA; Khan AA; Ngowi EE; Wu DD; Ji XY
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207362
[TBL] [Abstract][Full Text] [Related]
15. Variability in Codon Usage in Coronaviruses Is Mainly Driven by Mutational Bias and Selective Constraints on CpG Dinucleotide.
Daron J; Bravo IG
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578381
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive analysis of genome composition and codon usage patterns of emerging coronaviruses.
Tort FL; Castells M; Cristina J
Virus Res; 2020 Jul; 283():197976. PubMed ID: 32294518
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of SARS-CoV-2 clades based on signature SNPs unveils continuous evolution.
Ghosh N; Saha I; Nandi S; Sharma N
Methods; 2022 Jul; 203():282-296. PubMed ID: 34547443
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
Nambou K; Anakpa M
Infect Genet Evol; 2020 Nov; 85():104471. PubMed ID: 32707288
[TBL] [Abstract][Full Text] [Related]
19. The Mutational Landscape of SARS-CoV-2.
Saldivar-Espinoza B; Garcia-Segura P; Novau-Ferré N; Macip G; Martínez R; Puigbò P; Cereto-Massagué A; Pujadas G; Garcia-Vallve S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240420
[TBL] [Abstract][Full Text] [Related]
20. Natural selection plays a significant role in governing the codon usage bias in the novel SARS-CoV-2 variants of concern (VOC).
Tyagi N; Sardar R; Gupta D
PeerJ; 2022; 10():e13562. PubMed ID: 35765592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]